Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05688839
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-24
First Post:
2023-01-09
Brief Title:
A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
Sponsor:
Suzhou Zelgen Biopharmaceuticals CoLtd
Organization:
Suzhou Zelgen Biopharmaceuticals CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-09
First Submit QC Date:
January 9 2023
Study First Post Date:
2023-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-22
Last Update Post Date:
2023-10-24
Last Update Post Date Type:
ACTUAL